Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-13 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.050 | 0.0900 | ||||
REV | 40.000K | 50.030M | 49.990M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals | 13.09 | -0.32 | -2.39% | 1.7B |
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
Other companies in Aurinia Pharmaceuticals’s space includes: Precigen (NASDAQ:PGEN), Zentalis Pharmaceuticals (NASDAQ:ZNTL) and ADC Therapeutics (NYSE:ADCT).
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by SVB Leerink on 2021-01-27. The analyst firm set a price target for 28.00 expecting AUPH to rise to within 12 months (a possible 113.90% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $13.09 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Aurinia Pharmaceuticals.
There is no upcoming split for Aurinia Pharmaceuticals.